About ABLi Therapeutics
ABLi Therapeutics is a private company based in Atlanta, Georgia, incorporated in 2025 in Delaware. It has reported $1,000,000 raised in one offering on Form D since January 2026. Its chief executive is Milton Werner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2025 | Jan 13, 2026 | $1,000,000fully sold | 10 | $100K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ABLi Therapeutics's Form D filed Jan 13, 2026.
JY
Jeffrey Young
Director
MW
Milton Werner
Chief Executive Officer, President, and Secretary, director
GR
Garth Lees-Rolfe
Chief Financial Officer and Treasurer
AD
Anastasia Daifotis
Director